Johnson Pharmacare
BSE: 532154
₹ 0.39▼ 0.01 (−2.5%)28 Oct, 03:29 pm IST
- Market cap
- ₹ 21 Cr.
- P/E
- 153.2x
- P/B
- 49.29x
- 52-week range
- 0.37 – 0.7
- ROE
- −146%
- ROCE
- −105%
- Dividend yield
- 0%
- Debt / equity
- 49.18
- Sector
- Commercial Services & Supplies
- Industry
- Diversified Commercial Services
- Listed on
- BSE
About
Johnson Pharmacare Limited is an India-based company. The Company is not engaged in any business activities. It has not generated any revenues.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Diversified Commercial Services: 149 companies →Johnson Pharmacare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)153.2 against a typical 20: pricier than most peers (1st = cheapest).120th of 139
- Share price, 3 months−17% against a typical −8.9%.92nd of 121
- Size₹ 21.5 Cr. market value against a typical ₹ 68.8 Cr. (1st = largest).91st of 128
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43 | 0 |
| Operating Profit | 0 | 0 | 0 | −0 | 0 | −0 | −0 | −0 | 0 | −0 | −43 | −0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 | −13 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | −0 | 0 | −0 | −1 | −0 | 0 | −0 | −56 | −1 |
| Tax % | — | — | — | 0% | — | 0% | 0% | 0% | — | 0% | 0% | 0% |
| Net Profit | 0 | 0 | 0 | −0 | 0 | −0 | −1 | −0 | 0 | −0 | −56 | −1 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | −0.01 | 0 | 0 | 0 | −1.01 | −0.02 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −10,019%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- 13%
- 3 Years
- −2%
- TTM
- —
Return on Equity
- 10 Years
- −8%
- 5 Years
- −16%
- 3 Years
- −30%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 153.2xEPS (12 months) ₹ 0.01Median P/E 136.5x
P/E (times)EPS (₹)
Peers
Listed companies in the same business.
| Johnson Pharmacare | ₹ 0.39 | ₹ 21 Cr. | 153.2x | 49.3x | −146% | — |
| REC | ₹ 293.65 | ₹ 77,325 Cr. | 5.7x | 1.1x | 20% | 27.4% |
| Altius Telecom Infrastructure Trust | ₹ 170.00 | ₹ 0 Cr. | 46.7x | 4.5x | 8.3% | 4.6% |
| National Highways Infra Trust | ₹ 168.00 | ₹ 35,928 Cr. | 47.7x | 1.5x | 3% | 16% |
| IndiGrid Infrastructure Trust | ₹ 164.83 | ₹ 15,701 Cr. | 39.1x | 2.8x | 7% | 8.4% |
| Indus Infra Trust | ₹ 124.00 | ₹ 7,576 Cr. | 15x | 1.2x | — | 56.5% |
Management
- Hiteshkumar Manharbhai Patel
- Executive & Non Independent Chairman of the Board, Compliance Officer
- Ramanlal Nagjibhai Trivedi
- Chief Financial Officer, Whole Time Director
- Dheeraj Kumar
- Additional Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.